Memorial Sloan Kettering Cancer Center
Clinical trials sponsored by Memorial Sloan Kettering Cancer Center, explained in plain language.
-
New study tests which maintenance drug gives myeloma patients better quality of life
Disease control OngoingThis study compares two maintenance therapies—daratumumab and lenalidomide—for people with newly diagnosed multiple myeloma that responded well to initial treatment. The main goal is to see which drug provides better quality of life during treatment. About 95 participants will be…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
New MRI study could improve prostate cancer treatment Follow-Up
Knowledge-focused OngoingThis study uses advanced MRI scans to see how prostate cancer changes after radiation therapy. Researchers will compare MRI images with biopsy results to better understand treatment response. The goal is to help doctors manage prostate cancer more effectively and catch any issues…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC